D-1883-2019 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-1883-2019 was initiated by Akorn, Inc. on Sep 20, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Out of specification results for container closure test which cannot guarantee the sterility of the product. The recall status is terminated (terminated Aug 1, 2022). Affected quantity: 60,176 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 9, 2019
Initiation Date
Sep 20, 2019
Termination Date
Aug 1, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60,176 bottles

Product description

Phenylephrine Hydrochloride Ophthalmic Solution, USP, 2.5%, 15 mL bottle, Rx only, Mfd. by: Akorn, Inc., Lake Forest, IL 60045; NDC 17478-201-15.

Reason for recall

Lack of Assurance of Sterility: Out of specification results for container closure test which cannot guarantee the sterility of the product.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: 031908A, Exp 03/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1883-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1883-2019. Report a data issue: hello@regdatalab.com.